Jpmorgan Chase & CO Agile Therapeutics Inc Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.18 - $15.25 $49 - $4,193
275 Added 13750.0%
277 $0
Q3 2022

Nov 14, 2022
SELL
$0.28 - $14.85 $45 - $2,435
-164 Reduced 98.8%
2 $0
Q2 2022

Aug 11, 2022
BUY
$1.09 - $8.24 $180 - $1,367
166 New
166 $0

About AGILE THERAPEUTICS INC

AGRX Quotes by TradingView
  • Ticker AGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 39,023,000
  • Description
  • Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line exte...
More about AGRX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email